<?xml version="1.0" encoding="UTF-8"?>
<p id="para0010">Transplantation pharmacists should continuously monitor the potential drug toxicities and interactions of the medications given post-HCT via telehealth. In addition, the drug inventory should be evaluated at routine intervals for the essential drugs used for HCT patients. The use of any over-the-counter drugs or self-treatment with complementary and alternative medicine without discussion with the primary transplantation physician and the clinical pharmacist is not recommended. We refer the readers to the American Society for Transplantation and Cellular Therapyâ€™s pharmacy practice management guideline for COVID-19 patients 
 <xref rid="bib0011" ref-type="bibr">[11]</xref>.
</p>
